Quick Answer
MIMEDX GROUP, INC. reported Cash and Equivalents of $166.12 million for fiscal year 2025.
MIMEDX GROUP, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $166.12M | +59.1% |
| 2024 | $104.42M | +27.3% |
| 2023 | $82.00M | +24.3% |
| 2022 | $65.95M | -24.3% |
| 2021 | $87.08M | -9.1% |
| 2020 | $95.81M | +38.7% |
| 2019 | $69.07M | +53.1% |
| 2018 | $45.12M | +64.2% |
| 2017 | $27.48M | -9.4% |
| 2016 | $30.32M | +15.3% |
| 2015 | $26.30M | -43.5% |
| 2014 | $46.58M | +5.7% |
| 2013 | $44.08M | +552.6% |
| 2012 | $6.75M | +64.2% |
| 2011 | $4.11M | +206.7% |
| 2010 | $1.34M | -49.5% |
| 2009 | $2.65M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $142.08M | +60.0% | +19.5% |
| June 30, 2025 | $118.87M | +72.2% | +11.7% |
| March 31, 2025 | $106.43M | +119.5% | +1.9% |
| December 31, 2024 | $104.42M | +27.3% | +17.6% |
| September 30, 2024 | $88.80M | — | +28.6% |
| June 30, 2024 | $69.04M | +0.6% | +42.4% |
| March 31, 2024 | $48.49M | -20.8% | -40.9% |
| December 31, 2023 | $82.00M | +24.3% | +19.4% |
- MIMEDX GROUP, INC. showed an increase of +59.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2025 period, MIMEDX GROUP, INC.’s cash and equivalents has grown by 6160.4% (from $2.65 million to $166.12 million).
- The most recent figure is from MIMEDX GROUP, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: